Literature DB >> 32038937

Optimizing selection of candidates for lung cancer screening: role of comorbidity, frailty and life expectancy.

Shailesh Advani1,2, Dejana Braithwaite1.   

Abstract

Entities:  

Year:  2019        PMID: 32038937      PMCID: PMC6987350          DOI: 10.21037/tlcr.2019.10.03

Source DB:  PubMed          Journal:  Transl Lung Cancer Res        ISSN: 2218-6751


× No keyword cloud information.
  60 in total

1.  Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies.

Authors:  Jeanne S Mandelblatt; Natasha K Stout; Clyde B Schechter; Jeroen J van den Broek; Diana L Miglioretti; Martin Krapcho; Amy Trentham-Dietz; Diego Munoz; Sandra J Lee; Donald A Berry; Nicolien T van Ravesteyn; Oguzhan Alagoz; Karla Kerlikowske; Anna N A Tosteson; Aimee M Near; Amanda Hoeffken; Yaojen Chang; Eveline A Heijnsdijk; Gary Chisholm; Xuelin Huang; Hui Huang; Mehmet Ali Ergun; Ronald Gangnon; Brian L Sprague; Sylvia Plevritis; Eric Feuer; Harry J de Koning; Kathleen A Cronin
Journal:  Ann Intern Med       Date:  2016-01-12       Impact factor: 25.391

2.  Improving selection criteria for lung cancer screening. The potential role of emphysema.

Authors:  Pablo Sanchez-Salcedo; David O Wilson; Juan P de-Torres; Joel L Weissfeld; Juan Berto; Arantzazu Campo; Ana B Alcaide; Jesús Pueyo; Gorka Bastarrika; Luis M Seijo; Maria J Pajares; Ruben Pio; Luis M Montuenga; Javier J Zulueta
Journal:  Am J Respir Crit Care Med       Date:  2015-04-15       Impact factor: 21.405

Review 3.  Benefits and harms of CT screening for lung cancer: a systematic review.

Authors:  Peter B Bach; Joshua N Mirkin; Thomas K Oliver; Christopher G Azzoli; Donald A Berry; Otis W Brawley; Tim Byers; Graham A Colditz; Michael K Gould; James R Jett; Anita L Sabichi; Rebecca Smith-Bindman; Douglas E Wood; Amir Qaseem; Frank C Detterbeck
Journal:  JAMA       Date:  2012-06-13       Impact factor: 56.272

4.  An official American Thoracic Society/American College of Chest Physicians policy statement: implementation of low-dose computed tomography lung cancer screening programs in clinical practice.

Authors:  Renda Soylemez Wiener; Michael K Gould; Douglas A Arenberg; David H Au; Kathleen Fennig; Carla R Lamb; Peter J Mazzone; David E Midthun; Maryann Napoli; David E Ost; Charles A Powell; M Patricia Rivera; Christopher G Slatore; Nichole T Tanner; Anil Vachani; Juan P Wisnivesky; Sue H Yoon
Journal:  Am J Respir Crit Care Med       Date:  2015-10-01       Impact factor: 21.405

5.  Reduced lung-cancer mortality with low-dose computed tomographic screening.

Authors:  Denise R Aberle; Amanda M Adams; Christine D Berg; William C Black; Jonathan D Clapp; Richard M Fagerstrom; Ilana F Gareen; Constantine Gatsonis; Pamela M Marcus; JoRean D Sicks
Journal:  N Engl J Med       Date:  2011-06-29       Impact factor: 91.245

6.  Frailty as a predictor of surgical outcomes in older patients.

Authors:  Martin A Makary; Dorry L Segev; Peter J Pronovost; Dora Syin; Karen Bandeen-Roche; Purvi Patel; Ryan Takenaga; Lara Devgan; Christine G Holzmueller; Jing Tian; Linda P Fried
Journal:  J Am Coll Surg       Date:  2010-04-28       Impact factor: 6.113

7.  The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer.

Authors:  John K Field; Stephen W Duffy; David R Baldwin; Kate E Brain; Anand Devaraj; Tim Eisen; Beverley A Green; John A Holemans; Terry Kavanagh; Keith M Kerr; Martin Ledson; Kate J Lifford; Fiona E McRonald; Arjun Nair; Richard D Page; Mahesh Kb Parmar; Robert C Rintoul; Nicholas Screaton; Nicholas J Wald; David Weller; David K Whynes; Paula R Williamson; Ghasem Yadegarfar; David M Hansell
Journal:  Health Technol Assess       Date:  2016-05       Impact factor: 4.014

8.  Evaluation of the lung cancer risks at which to screen ever- and never-smokers: screening rules applied to the PLCO and NLST cohorts.

Authors:  Martin C Tammemägi; Timothy R Church; William G Hocking; Gerard A Silvestri; Paul A Kvale; Thomas L Riley; John Commins; Christine D Berg
Journal:  PLoS Med       Date:  2014-12-02       Impact factor: 11.069

Review 9.  Autoantibodies as diagnostic biomarkers for lung cancer: A systematic review.

Authors:  Bin Yang; Xiaoyan Li; Tianyi Ren; Yiyu Yin
Journal:  Cell Death Discov       Date:  2019-08-05

10.  UK Lung Cancer RCT Pilot Screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening.

Authors:  J K Field; S W Duffy; D R Baldwin; D K Whynes; A Devaraj; K E Brain; T Eisen; J Gosney; B A Green; J A Holemans; T Kavanagh; K M Kerr; M Ledson; K J Lifford; F E McRonald; A Nair; R D Page; M K B Parmar; D M Rassl; R C Rintoul; N J Screaton; N J Wald; D Weller; P R Williamson; G Yadegarfar; D M Hansell
Journal:  Thorax       Date:  2015-12-08       Impact factor: 9.139

View more
  3 in total

1.  Prevalence And Impact of Medical Comorbidities in A Real-World Lung Cancer Screening Population.

Authors:  Harris Majeed; Hong Zhu; Sarah A Williams; Heidi A Hamann; Vijaya Subbu Natchimuthu; Jessica Lee; Noel O Santini; Travis Browning; Tanushree Prasad; Joyce O Adesina; Minh Do; David Balis; Juana Gamarra de Willams; Ellen Kitchell; David H Johnson; Simon J Craddock Lee; David E Gerber
Journal:  Clin Lung Cancer       Date:  2022-04-29       Impact factor: 4.840

2.  Comparative performance of lung cancer risk models to define lung screening eligibility in the United Kingdom.

Authors:  Hilary A Robbins; Karine Alcala; Anthony J Swerdlow; Minouk J Schoemaker; Nick Wareham; Ruth C Travis; Philip A J Crosbie; Matthew Callister; David R Baldwin; Rebecca Landy; Mattias Johansson
Journal:  Br J Cancer       Date:  2021-04-12       Impact factor: 9.075

3.  The Impact of Race-Ethnicity and Diagnosis of Alzheimer's Disease and Related Dementias on Mammography Use.

Authors:  Aokun Chen; Yongqiu Li; Jennifer N Woodard; Jessica Y Islam; Shuang Yang; Thomas J George; Elizabeth A Shenkman; Jiang Bian; Yi Guo
Journal:  Cancers (Basel)       Date:  2022-09-28       Impact factor: 6.575

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.